AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

The Usage of 1,3,5,7-tetrahydroxy-8-isoprenylxanthone, a Natural Compound from Garcinia Esculenta Y. H. Li, as Anti-inflammation Drugs

Summary
This invention relates to a chemical entity isolated from natural sources for its therapeutic uses.
Technology Benefits
Providing a natural compound from a natural source that exhibits potent anti-inflammatory effect
Technology Application
The compound can be developed as potential anti-inflammatory drugs
Detailed Technology Description
It relates to a compound 1,3,5,7-tetrahydroxy-8-isoprenylxanthone (TI), that is naturally occurring in the plant of Garcinia esculenta Y. H. Li, and its biological activity of inhibiting nitric oxide production and microRNA 155 expression in stimulated macrophages, which can be developed as potential anti-inflammatory drugs.
Supplementary Information
Inventor: LI, Lian-kui
Priority Number: CN101085163A
IPC Current: A61K0036896 | A61K003334 | A61K003555 | A61P003500
Title: Chinese medicinal herb for treating cancer | Chinese tradition medicinal herb for treating cancer
Usefulness: Chinese medicinal herb for treating cancer | Chinese tradition medicinal herb for treating cancer
Summary: For treating the cancer (e.g., lung cancer, liver cancer, gastric cancer, breast carcinoma, nose cancer, and esophagus cancer).
Novelty: Oral traditional Chinese medicinal herb for treating cancer (e.g. lung cancer) comprises Herba pellioniae radicantis, Herba catharanthi rosei, Scutellaria barbata, Chinese brake herb, Wahlenbergia marginate, Psychotria serpens
Industry
Disease Diagnostic/Treatment
Sub Category
Cancer/Tumor
Application Date
2013.01.11
Application No.
US 61/751,308
Others
Filed
ID No.
A61/BZ/Tetr/US0P
Country/Region
Hong Kong

For more information, please click Here
Mobile Device